Simpler Grants.gov #RFA-DA-26-058

NIH Forecast: Center for SUD Pharmacotherapeutics Training and Preclinical Support

The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is forecasting a cooperative agreement opportunity to establish a Center focused on substance use disorder (SUD) pharmacotherapeutics. - Government Buyer: - National Institutes of Health (NIH) - National Institute on Drug Abuse (NIDA) - Purpose: - Establish a Center to advance SUD pharmacotherapeutics - Educate and support researchers in formal product development for new SUD treatments - Provide technical and financial support for initial (preclinical) experiments - Requirements: - Develop a product development curriculum for SUD pharmacotherapeutics - Implement outreach and networking initiatives to engage the research community - Build infrastructure to support early-stage, preclinical experiments - No clinical trials permitted under this funding mechanism - Eligibility: - Open to government agencies, nonprofits, educational institutions, businesses, tribal organizations, and foreign institutions - OEMs and Vendors: - No specific OEMs or vendors are named, as this is a grant opportunity for institutional applicants - Unique/Notable Aspects: - Emphasis on training, outreach, and infrastructure for preclinical research - Designed to foster collaboration and support early-stage SUD treatment development

Description

The National Institute on Drug Abuse (NIDA) aims to establish a Center to educate and support researchers in product development for new substance use disorder pharmacotherapeutics. The Center will provide technical and financial support to advance promising concepts through initial experiments. Applicants are encouraged to develop a product development curriculum, outreach initiatives, and infrastructure support for initial experiments. This notice is to allow potential applicants time to prepare; applications are not currently being solicited.

View original listing